Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Robert R Jenq, Carles Ubeda, Ying Taur, Clarissa C Menezes, Raya Khanin, Jarrod A Dudakov, Chen Liu, Mallory L West, Natalie V Singer, Michele J Equinda, Asia Gobourne, Lauren Lipuma, Lauren F Young, Odette M Smith, Arnab Ghosh, Alan M Hanash, Jenna D Goldberg, Kazutoshi Aoyama, Bruce R Blazar, Eric G Pamer, Marcel R M van den Brink, Robert R Jenq, Carles Ubeda, Ying Taur, Clarissa C Menezes, Raya Khanin, Jarrod A Dudakov, Chen Liu, Mallory L West, Natalie V Singer, Michele J Equinda, Asia Gobourne, Lauren Lipuma, Lauren F Young, Odette M Smith, Arnab Ghosh, Alan M Hanash, Jenna D Goldberg, Kazutoshi Aoyama, Bruce R Blazar, Eric G Pamer, Marcel R M van den Brink
Abstract
Despite a growing understanding of the link between intestinal inflammation and resident gut microbes, longitudinal studies of human flora before initial onset of intestinal inflammation have not been reported. Here, we demonstrate in murine and human recipients of allogeneic bone marrow transplantation (BMT) that intestinal inflammation secondary to graft-versus-host disease (GVHD) is associated with major shifts in the composition of the intestinal microbiota. The microbiota, in turn, can modulate the severity of intestinal inflammation. In mouse models of GVHD, we observed loss of overall diversity and expansion of Lactobacillales and loss of Clostridiales. Eliminating Lactobacillales from the flora of mice before BMT aggravated GVHD, whereas reintroducing the predominant species of Lactobacillus mediated significant protection against GVHD. We then characterized gut flora of patients during onset of intestinal inflammation caused by GVHD and found patterns mirroring those in mice. We also identified increased microbial chaos early after allogeneic BMT as a potential risk factor for subsequent GVHD. Together, these data demonstrate regulation of flora by intestinal inflammation and suggest that flora manipulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients.
Figures
References
- Beelen D.W., Elmaagacli A., Müller K.D., Hirche H., Schaefer U.W. 1999. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood. 93:3267–3275
- Blazar B.R., Taylor P.A., Boyer M.W., Panoskaltsis-Mortari A., Allison J.P., Vallera D.A. 1997. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells. J. Immunol. 159:3460–3473
- Blazar B.R., Lees C.J., Martin P.J., Noelle R.J., Kwon B., Murphy W., Taylor P.A. 2000. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J. Immunol. 165:4901–4909
- Buhnik-Rosenblau K., Danin-Poleg Y., Kashi Y. 2011. Predominant effect of host genetics on levels of Lactobacillus johnsonii bacteria in the mouse gut. Appl. Environ. Microbiol. 77:6531–6538 10.1128/AEM.00324-11
- Cooke K.R., Kobzik L., Martin T.R., Brewer J., Delmonte J., Jr, Crawford J.M., Ferrara J.L. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 88:3230–3239
- Dethlefsen L., Huse S., Sogin M.L., Relman D.A. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280 10.1371/journal.pbio.0060280
- Dubberke E.R., Hollands J.M., Georgantopoulos P., Augustin K., DiPersio J.F., Mundy L.M., Khoury H.J. 2006. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant. 38:813–819 10.1038/sj.bmt.1705530
- Ferrara J.L., Levine J.E., Reddy P., Holler E. 2009. Graft-versus-host disease. Lancet. 373:1550–1561 10.1016/S0140-6736(09)60237-3
- Gerbitz A., Schultz M., Wilke A., Linde H.J., Schölmerich J., Andreesen R., Holler E. 2004. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood. 103:4365–4367 10.1182/blood-2003-11-3769
- Heimesaat M.M., Nogai A., Bereswill S., Plickert R., Fischer A., Loddenkemper C., Steinhoff U., Tchaptchet S., Thiel E., Freudenberg M.A., et al. 2010. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut. 59:1079–1087 10.1136/gut.2009.197434
- Hill G.R., Crawford J.M., Cooke K.R., Brinson Y.S., Pan L., Ferrara J.L. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 90:3204–3213
- Jones J.M., Wilson R., Bealmear P.M. 1971. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat. Res. 45:577–588 10.2307/3573066
- Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. 2011. Human nutrition, the gut microbiome and the immune system. Nature. 474:327–336 10.1038/nature10213
- Kim S.O., Sheikh H.I., Ha S.D., Martins A., Reid G. 2006. G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell. Microbiol. 8:1958–1971 10.1111/j.1462-5822.2006.00763.x
- Korngold R., Sprent J. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148:1687–1698 10.1084/jem.148.6.1687
- Lozupone C., Hamady M., Knight R. 2006. UniFrac—an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics. 7:371 10.1186/1471-2105-7-371
- Magurran A.E. 2004. Measuring Biological Diversity. Blackwell Pub., Malden, Ma. 256 pages.
- Maloy K.J., Powrie F. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 474:298–306 10.1038/nature10208
- Manson J.M., Rauch M., Gilmore M.S. 2008. The commensal microbiology of the gastrointestinal tract. Adv. Exp. Med. Biol. 635:15–28 10.1007/978-0-387-09550-9_2
- Passweg J.R., Rowlings P.A., Atkinson K.A., Barrett A.J., Gale R.P., Gratwohl A., Jacobsen N., Klein J.P., Ljungman P., Russell J.A., et al. 1998. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant. 21:1231–1238 10.1038/sj.bmt.1701238
- Penack O., Smith O.M., Cunningham-Bussel A., Liu X., Rao U., Yim N., Na I.K., Holland A.M., Ghosh A., Lu S.X., et al. 2009. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 206:2101–2110 10.1084/jem.20090623
- Penack O., Henke E., Suh D., King C.G., Smith O.M., Na I.K., Holland A.M., Ghosh A., Lu S.X., Jenq R.R., et al. 2010. Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J. Natl. Cancer Inst. 102:894–908 10.1093/jnci/djq172
- Petersen F.B., Buckner C.D., Clift R.A., Nelson N., Counts G.W., Meyers J.D., Thomas E.D. 1987. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scand. J. Infect. Dis. 19:559–567 10.3109/00365548709032423
- Pridmore R.D., Berger B., Desiere F., Vilanova D., Barretto C., Pittet A.C., Zwahlen M.C., Rouvet M., Altermann E., Barrangou R., et al. 2004. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proc. Natl. Acad. Sci. USA. 101:2512–2517 10.1073/pnas.0307327101
- Reddy P., Ferrara J.L.M.2008. Mouse models of graft-versus-host disease. In StemBook. Lisa Gerard, editor. StemBook, Cambridge, MA. .
- Russell J.A., Chaudhry A., Booth K., Brown C., Woodman R.C., Valentine K., Stewart D., Ruether J.D., Ruether B.A., Jones A.R., et al. 2000. Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: a 10-year experience. Biol. Blood Marrow Transplant. 6:109–114 10.1016/S1083-8791(00)70073-5
- Sayegh M.H., Wu Z., Hancock W.W., Langmuir P.B., Mata M., Sandner S., Kishimoto K., Sho M., Palmer E., Mitchell R.N., Turka L.A. 2003. Allograft rejection in a new allospecific CD4+ TCR transgenic mouse. Am. J. Transplant. 3:381–389 10.1034/j.1600-6143.2003.00062.x
- Schloss P.D., Westcott S.L., Ryabin T., Hall J.R., Hartmann M., Hollister E.B., Lesniewski R.A., Oakley B.B., Parks D.H., Robinson C.J., et al. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:7537–7541 10.1128/AEM.01541-09
- Schroeder M.A., DiPersio J.F. 2011. Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech. 4:318–333 10.1242/dmm.006668
- Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. 2010. Gut microbiota in health and disease. Physiol. Rev. 90:859–904 10.1152/physrev.00045.2009
- Steck N., Hoffmann M., Sava I.G., Kim S.C., Hahne H., Tonkonogy S.L., Mair K., Krueger D., Pruteanu M., Shanahan F., et al. 2011. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 141:959–971 10.1053/j.gastro.2011.05.035
- Storb R., Prentice R.L., Buckner C.D., Clift R.A., Appelbaum F., Deeg J., Doney K., Hansen J.A., Mason M., Sanders J.E., et al. 1983. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N. Engl. J. Med. 308:302–307 10.1056/NEJM198302103080602
- Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., Samstein M., Viale A., Socci N.D., van den Brink M.R.M., Kamboj M., Pamer E.G. 2010. Intestinal domination by Vancomycin-resistant Enterococcus precedes bloodstream invasion in humans. J. Clin. Invest. In press
- van Bekkum D.W., Roodenburg J., Heidt P.J., van der Waaij D. 1974. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J. Natl. Cancer Inst. 52:401–404
- Wang Q., Garrity G.M., Tiedje J.M., Cole J.R. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73:5261–5267 10.1128/AEM.00062-07
- Willing B.P., Russell S.L., Finlay B.B. 2011. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 9:233–243 10.1038/nrmicro2536
- Woodmansey E.J. 2007. Intestinal bacteria and ageing. J. Appl. Microbiol. 102:1178–1186 10.1111/j.1365-2672.2007.03400.x
Source: PubMed